The treatment, called chemosaturation ... from Trafford said she was "not ready to give up" and wanted to see her children ...

Study findings show that the standardized 6-month surveillance protocols for all patients with low-risk uveal melanoma may be ...

Katie Doble is on her computer looking to connect with anyone who might share her fight for clinical research knowing her life and countless others depend on it.

A new way to deliver cancer medicine directly to the liver may help patients with a rare and aggressive type of eye cancer ...

The Melphalan/Hepatic Delivery System is a drug or medical device combination used for liver-directed treatment of ...

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to ...

Following a recent Type D meeting with the FDA, a phase 3 clinical trial design for darovasertib in primary uveal melanoma ...

Unlike the 90% of melanomas caused by UV exposure, the rare ocular, acral and mucosal melanoma subtypes have no known environmental risk factors, making early detection and treatment challenging.

A recent study has shown that a new drug delivery method can successfully treat a rare type of eye cancer. Scientists tested ...